Business Case Studies, Mergers, Acquisitions and Takeovers Case Study, Novartis' Acquisition of Aventis, The Potential Synergies

print page
Tell A Friend
Bookmark
 

Case Categories

Mergers, Acquisitions and Takeovers Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

Novartis' Acquisition of Aventis : The Potential Synergies

Publication Year : 2004

Authors: V. Bala Kiran, Sumit Kumar Chaudhuri

Industry: Health Care

Region:France

Case Code: MAA0011

Teaching Note: Not Available

Structured Assignment: Not Available

Buy This Case Study
OR





Abstract:
After Aventis rejected the hostile takeover bid of Sanofi-Synthelabo on the grounds of financial inadequacy in January 2004, it approached Novartis, the Swiss drug manufacturer, to acquire it and save it from the potential acquisition. Although the Novartis-Aventis combination had the potential to form the second largest pharmaceutical company in the world with combined revenues of $47 billion, the French government was against the takeover of Aventis by a foreign company.

Pedagogical Objectives:

  • To discuss the probable synergies in case Aventis is acquired by Novartis.

Keywords : Ciba-Geigy;Mergers, Acquisitions, Alliances Case Study; Sandoz; Global pharmaceutical companies; Mergers and acquisitions; Sanofi-Synthelabo; Aventis; Novartis AG; Hostile takeovers; Hoechst AG; Prescription drugs; Rhone-Poulenc SA; Pfizer; Merk & Company; Anti-diabetic drugs; Anti-cancerous drugs

Contents : 
A Briefoverviewof The Companies
The Probable Synergies
A Challengingfuture
Mergers And Acquisitions In The Global Pharmaceutical Industry
Bad Chemistry
Sales Of The Ten Best Selling Drugs Of Novartis
Aventis And Novartis: Product Classification Accordin

Recently Bought Case Studies

    Recently Bought Case Studies
advertisement

    Executive Interviews

  • George G BrenkertGeorge G Brenkert

    Professor of Business Ethics at the McDonough School of Business of Georgetown University
    Speaks on Building Ethical Organizations
  • Dr. Bala V BalachandranDr. Bala V Balachandran

    Dr. Bala V Balachandran, Founder and Honorary Dean of Great Lakes Inistitute of Management
    Speaks on Government and Business
  • Eileen FischerEileen Fischer

    Eileen Fischer, is a Professor of Marketing and the Anne and Max Tanenbaum Chair in Entrepreneurship and Family Enterprise.
    Speaks on Steve Jobs
  • View All Executive Interviews»






Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501 504, Andhra Pradesh, INDIA.
Mob: +91- 9640901313, Phone: +91 - 08417 - 236672, Fax : + 91 - 08417 - 236674
E-mail: casehelpdesk@ibsindia.org

©2003-2010 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap